Research AI

Scans

Tools

Watchlists

Home

Charts

Watchlist

Products

Healthcare Global Enterprises Ltd

HCG

NSE

₹569.70-3.15%19 Oct 2026

Reports

Hospitals

Healthcare Global Enterprises Ltd

HCG

NSE

₹569.70

-3.15%

19 Oct 2026

SOICxStockScans Reports

Ask AI

Hospitals

Indices

Quick Ratios

Quarterly Results

Profit & Loss

Balance Sheet

Cash Flow

Ratios

Peer Comparison

Quick Ratios

Quarterly Results

Profit & Loss

Balance Sheet

Cash Flow

Ratios

Peer Comparison

Price

Charts

Documents

Edit Ratios

Mkt Cap

Market Capitalization

₹8,510Cr

Close Price

₹570.00

Industry

Hospitals

Price To Earnings

370.13

Price To Sales

3.24

Revenue

₹2,627Cr

Rev Gr TTM

Revenue Growth TTM

13.72%

PAT Gr TTM

PAT Growth TTM

-19.23%

Upcoming Results on

5 Nov 2026

Consolidated

Standalone

Numbers

Percentage

Quarter	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue RevenueCr	487	470	495	526	554	559	585	613	647	633	652	695
Growth YoY Revenue Growth YoY%	15.9	10.6	12.0	14.1	13.7	18.9	18.3	16.7	16.9	13.3	11.5	13.4
Expenses ExpensesCr	402	391	403	435	451	470	479	505	524	523	527	573
Operating Profit Operating ProfitCr	85	79	92	91	102	88	106	108	123	110	125	122
OPM OPM%	17.4	16.7	18.6	17.3	18.5	15.8	18.1	17.6	19.1	17.3	19.2	17.6
Other Income Other IncomeCr	3	6	9	9	11	6	10	8	3	-10	-18	13
Interest Expense Interest ExpenseCr	27	29	27	34	36	41	44	45	44	45	43	40
Depreciation DepreciationCr	43	44	46	47	50	57	58	58	63	61	63	70
PBT PBTCr	18	11	28	19	28	-3	14	12	20	-6	1	25
Tax TaxCr	7	8	5	5	7	-11	7	6	-1	2	-3	9
PAT PATCr	11	3	23	14	21	8	7	6	21	-8	4	16
Growth YoY PAT Growth YoY%	103.8	-18.3	315.2	273.4	91.8	126.0	-71.1	-56.1	-0.1	-201.9	-40.3	175.3
NPM NPM%	2.2	0.7	4.7	2.6	3.7	1.4	1.2	1.0	3.2	-1.3	0.6	2.4
EPS EPS₹	1.0	0.4	1.5	0.9	1.3	0.5	0.5	0.3	1.1	-0.7	0.1	0.9

Quarter	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue RevenueCr	487	470	495	526	554	559	585	613	647	633	652	695
Growth YoY Revenue Growth YoY%	15.9	10.6	12.0	14.1	13.7	18.9	18.3	16.7	16.9	13.3	11.5	13.4
Expenses ExpensesCr	402	391	403	435	451	470	479	505	524	523	527	573
Operating Profit Operating ProfitCr	85	79	92	91	102	88	106	108	123	110	125	122
OPM OPM%	17.4	16.7	18.6	17.3	18.5	15.8	18.1	17.6	19.1	17.3	19.2	17.6
Other Income Other IncomeCr	3	6	9	9	11	6	10	8	3	-10	-18	13
Interest Expense Interest ExpenseCr	27	29	27	34	36	41	44	45	44	45	43	40
Depreciation DepreciationCr	43	44	46	47	50	57	58	58	63	61	63	70
PBT PBTCr	18	11	28	19	28	-3	14	12	20	-6	1	25
Tax TaxCr	7	8	5	5	7	-11	7	6	-1	2	-3	9
PAT PATCr	11	3	23	14	21	8	7	6	21	-8	4	16
Growth YoY PAT Growth YoY%	103.8	-18.3	315.2	273.4	91.8	126.0	-71.1	-56.1	-0.1	-201.9	-40.3	175.3
NPM NPM%	2.2	0.7	4.7	2.6	3.7	1.4	1.2	1.0	3.2	-1.3	0.6	2.4
EPS EPS₹	1.0	0.4	1.5	0.9	1.3	0.5	0.5	0.3	1.1	-0.7	0.1	0.9

Consolidated

Standalone

Numbers

Percentage

Financial Year	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Revenue RevenueCr	582	700	829	976	1,092	1,009	1,395	1,691	1,908	2,218	2,538	2,627
Growth Revenue Growth%	12.1	20.3	18.4	17.8	11.9	-7.6	38.2	21.3	12.8	16.3	14.4	13.7
Expenses ExpensesCr	492	595	712	853	923	887	1,160	1,396	1,583	1,836	2,080	2,147
Operating Profit Operating ProfitCr	90	105	117	123	169	122	235	296	325	383	459	480
OPM OPM%	15.4	15.0	14.1	12.6	15.5	12.1	16.9	17.5	17.1	17.3	18.1	18.3
Other Income Other IncomeCr	-3	10	24	-1	-2	-73	109	16	25	40	-11	-13
Interest Expense Interest ExpenseCr	38	23	42	70	138	119	98	104	109	155	177	171
Depreciation DepreciationCr	44	57	71	85	148	159	158	163	174	211	244	257
PBT PBTCr	5	35	27	-33	-119	-229	88	45	68	57	27	40
Tax TaxCr	0	12	10	-3	6	-8	49	27	26	8	4	7
PAT PATCr	5	23	17	-31	-125	-221	39	18	41	49	23	33
Growth PAT Growth%	15.7	324.1	-26.5	-282.3	-306.3	-76.2	117.6	-54.7	134.4	18.1	-53.4	-19.2
NPM NPM%	0.9	3.3	2.0	-3.2	-11.5	-21.9	2.8	1.0	2.2	2.2	0.9	1.3
EPS EPS₹	0.3	2.7	2.4	-2.8	-12.0	-16.9	4.1	2.1	3.4	3.2	1.0	1.5

Financial Year	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Revenue RevenueCr	582	700	829	976	1,092	1,009	1,395	1,691	1,908	2,218	2,538	2,627
Growth Revenue Growth%	12.1	20.3	18.4	17.8	11.9	-7.6	38.2	21.3	12.8	16.3	14.4	13.7
Expenses ExpensesCr	492	595	712	853	923	887	1,160	1,396	1,583	1,836	2,080	2,147
Operating Profit Operating ProfitCr	90	105	117	123	169	122	235	296	325	383	459	480
OPM OPM%	15.4	15.0	14.1	12.6	15.5	12.1	16.9	17.5	17.1	17.3	18.1	18.3
Other Income Other IncomeCr	-3	10	24	-1	-2	-73	109	16	25	40	-11	-13
Interest Expense Interest ExpenseCr	38	23	42	70	138	119	98	104	109	155	177	171
Depreciation DepreciationCr	44	57	71	85	148	159	158	163	174	211	244	257
PBT PBTCr	5	35	27	-33	-119	-229	88	45	68	57	27	40
Tax TaxCr	0	12	10	-3	6	-8	49	27	26	8	4	7
PAT PATCr	5	23	17	-31	-125	-221	39	18	41	49	23	33
Growth PAT Growth%	15.7	324.1	-26.5	-282.3	-306.3	-76.2	117.6	-54.7	134.4	18.1	-53.4	-19.2
NPM NPM%	0.9	3.3	2.0	-3.2	-11.5	-21.9	2.8	1.0	2.2	2.2	0.9	1.3
EPS EPS₹	0.3	2.7	2.4	-2.8	-12.0	-16.9	4.1	2.1	3.4	3.2	1.0	1.5

Consolidated

Standalone

Numbers

Percentage

Financial Year	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital Equity CapitalCr	85	86	87	88	89	125	139	139	139	139	149
Reserves ReservesCr	451	347	398	389	293	528	731	721	686	783	1,183
Current Liabilities Current LiabilitiesCr	195	366	359	547	576	465	470	570	744	1,046	1,017
Non Current Liabilities Non Current LiabilitiesCr	270	371	506	584	1,258	856	866	876	1,099	1,507	1,495
Total Liabilities Total LiabilitiesCr	1,034	1,226	1,444	1,654	2,253	2,036	2,220	2,316	2,708	3,543	3,923
Current Assets Current AssetsCr	200	244	220	273	304	435	502	580	680	844	1,135
Non Current Assets Non Current AssetsCr	834	982	1,224	1,381	1,949	1,601	1,717	1,736	2,028	2,699	2,787
Total Assets Total AssetsCr	1,034	1,226	1,444	1,654	2,253	2,036	2,220	2,316	2,708	3,543	3,923

Financial Year	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital Equity CapitalCr	85	86	87	88	89	125	139	139	139	139	149
Reserves ReservesCr	451	347	398	389	293	528	731	721	686	783	1,183
Current Liabilities Current LiabilitiesCr	195	366	359	547	576	465	470	570	744	1,046	1,017
Non Current Liabilities Non Current LiabilitiesCr	270	371	506	584	1,258	856	866	876	1,099	1,507	1,495
Total Liabilities Total LiabilitiesCr	1,034	1,226	1,444	1,654	2,253	2,036	2,220	2,316	2,708	3,543	3,923
Current Assets Current AssetsCr	200	244	220	273	304	435	502	580	680	844	1,135
Non Current Assets Non Current AssetsCr	834	982	1,224	1,381	1,949	1,601	1,717	1,736	2,028	2,699	2,787
Total Assets Total AssetsCr	1,034	1,226	1,444	1,654	2,253	2,036	2,220	2,316	2,708	3,543	3,923

Consolidated

Standalone

Financial Year	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Operating Cash Flow Operating Cash FlowCr	69	91	98	99	130	121	220	252	285	317	347
Investing Cash Flow Investing Cash FlowCr	-202	-210	-282	-238	-101	-171	125	-133	-226	-488	-177
Financing Cash Flow Financing Cash FlowCr	190	89	161	84	-58	112	-155	-140	-64	-42	241
Net Cash Flow Net Cash FlowCr	57	-29	-23	-56	-30	62	190	-22	-5	-213	410
Free Cash Flow Free Cash FlowCr	69	-101	-158	-90	23	85	150	126	101	110	59
CFO To PAT CFO To PAT%	1,269.4	396.1	577.5	-319.0	-103.7	-54.5	565.5	1,427.1	688.5	649.4	1,524.1
CFO To EBITDA CFO To EBITDA%	76.9	86.9	83.7	80.4	77.1	98.5	93.7	85.1	87.5	82.9	75.7

Financial Year	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Operating Cash Flow Operating Cash FlowCr	69	91	98	99	130	121	220	252	285	317	347
Investing Cash Flow Investing Cash FlowCr	-202	-210	-282	-238	-101	-171	125	-133	-226	-488	-177
Financing Cash Flow Financing Cash FlowCr	190	89	161	84	-58	112	-155	-140	-64	-42	241
Net Cash Flow Net Cash FlowCr	57	-29	-23	-56	-30	62	190	-22	-5	-213	410
Free Cash Flow Free Cash FlowCr	69	-101	-158	-90	23	85	150	126	101	110	59
CFO To PAT CFO To PAT%	1,269.4	396.1	577.5	-319.0	-103.7	-54.5	565.5	1,427.1	688.5	649.4	1,524.1
CFO To EBITDA CFO To EBITDA%	76.9	86.9	83.7	80.4	77.1	98.5	93.7	85.1	87.5	82.9	75.7

Consolidated

Standalone

Financial Year	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	Current
Valuation Ratios Valuation Ratios
Market Cap Market CapitalizationCr	1,523	1,976	2,545	1,894	665	2,395	3,752	3,655	4,711	7,501	7,834	8,510
Price To Earnings Price To Earnings		89.0	124.1				69.7	124.5	97.8	168.7	570.3	370.1
Price To Sales Price To Sales	2.6	2.8	3.1	1.9	0.6	2.4	2.7	2.2	2.5	3.4	3.1	3.2
Price To Book Price To Book	3.6	4.6	5.3	4.0	1.7	3.7	4.3	4.3	5.7	8.1	5.9	6.4
EV To EBITDA EV To EBITDA	19.7	21.1	24.7	19.9	11.2	27.2	19.0	14.7	17.5	23.5	19.7	20.8
Profitability Ratios Profitability Ratios
GPM GPM%	69.1	68.4	69.7	70.2	70.0	67.4	67.5	68.0	46.8	45.8	45.0	45.0
OPM OPM%	15.4	15.0	14.1	12.6	15.5	12.1	16.9	17.5	17.1	17.3	18.1	18.3
NPM NPM%	0.9	3.3	2.0	-3.2	-11.5	-21.9	2.8	1.0	2.2	2.2	0.9	1.3
ROCE ROCE%	5.3	7.6	8.1	3.5	1.1	-6.7	10.4	8.4	8.4	7.7	6.6	6.6
ROE ROE%	1.0	5.3	3.5	-6.5	-32.9	-33.8	4.5	2.0	5.0	5.3	1.7	1.7
ROA ROA%	0.5	1.9	1.2	-1.9	-5.6	-10.9	1.8	0.8	1.5	1.4	0.6	0.6
Operational Ratios Operational Ratios
Solvency Ratios Solvency Ratios
Liquidity Ratios Liquidity Ratios

Financial Year	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	Current
Valuation Ratios Valuation Ratios
Market Cap Market CapitalizationCr	1,523	1,976	2,545	1,894	665	2,395	3,752	3,655	4,711	7,501	7,834	8,510
Price To Earnings Price To Earnings		89.0	124.1				69.7	124.5	97.8	168.7	570.3	370.1
Price To Sales Price To Sales	2.6	2.8	3.1	1.9	0.6	2.4	2.7	2.2	2.5	3.4	3.1	3.2
Price To Book Price To Book	3.6	4.6	5.3	4.0	1.7	3.7	4.3	4.3	5.7	8.1	5.9	6.4
EV To EBITDA EV To EBITDA	19.7	21.1	24.7	19.9	11.2	27.2	19.0	14.7	17.5	23.5	19.7	20.8
Profitability Ratios Profitability Ratios
GPM GPM%	69.1	68.4	69.7	70.2	70.0	67.4	67.5	68.0	46.8	45.8	45.0	45.0
OPM OPM%	15.4	15.0	14.1	12.6	15.5	12.1	16.9	17.5	17.1	17.3	18.1	18.3
NPM NPM%	0.9	3.3	2.0	-3.2	-11.5	-21.9	2.8	1.0	2.2	2.2	0.9	1.3
ROCE ROCE%	5.3	7.6	8.1	3.5	1.1	-6.7	10.4	8.4	8.4	7.7	6.6	6.6
ROE ROE%	1.0	5.3	3.5	-6.5	-32.9	-33.8	4.5	2.0	5.0	5.3	1.7	1.7
ROA ROA%	0.5	1.9	1.2	-1.9	-5.6	-10.9	1.8	0.8	1.5	1.4	0.6	0.6
Operational Ratios Operational Ratios
Solvency Ratios Solvency Ratios
Liquidity Ratios Liquidity Ratios

	KIMS	RAINBOW	YATHARTH	HCG	JLHL	KOVAI	ARTEMISMED
Market CapitalizationMkt CapCr	28,388	12,635	9,327	8,510	8,002	6,427	4,777
Close PriceClose₹	675.90	1,244.00	968.00	570.00	244.10	5,874.00	301.75
IndustryIndustry	Hospitals	Hospitals	Hospitals	Hospitals	Hospitals	Hospitals	Hospitals
Price To EarningsPE	132.53	44.25	51.49	370.13	42.67	25.08	41.97
Price To SalesPS	6.74	6.94	6.99	3.24	5.14	3.91	4.29
RevenueRevenueCr	4,213	1,820	1,334	2,627	1,558	1,644	1,114
Revenue Growth TTMRev Gr TTM%	30.9%	18.3%	44.0%	13.7%	14.8%	15.0%	15.0%
PAT Growth TTMPAT Gr TTM%	-51.9%	12.4%	22.7%	-19.2%	-2.9%	16.3%	31.2%

	KIMS	RAINBOW	YATHARTH	HCG	JLHL	KOVAI	ARTEMISMED
Market CapitalizationMkt CapCr	28,388	12,635	9,327	8,510	8,002	6,427	4,777
Close PriceClose₹	675.90	1,244.00	968.00	570.00	244.10	5,874.00	301.75
IndustryIndustry	Hospitals	Hospitals	Hospitals	Hospitals	Hospitals	Hospitals	Hospitals
Price To EarningsPE	132.53	44.25	51.49	370.13	42.67	25.08	41.97
Price To SalesPS	6.74	6.94	6.99	3.24	5.14	3.91	4.29
RevenueRevenueCr	4,213	1,820	1,334	2,627	1,558	1,644	1,114
Revenue Growth TTMRev Gr TTM%	30.9%	18.3%	44.0%	13.7%	14.8%	15.0%	15.0%
PAT Growth TTMPAT Gr TTM%	-51.9%	12.4%	22.7%	-19.2%	-2.9%	16.3%	31.2%